Efficient capture and isolation of tumor-related circulating cell-free dna from cancer patients using electroactive conducting polymer nanowire platforms

Theranostics

Volumn 6, Issue 6, 2016, Pages 828-836

  Jeon, Seung Hyun ^a,b   Lee, Hyung Jae ^a,c   Bae, Kieun ^a   Yoon, Kyong Ah ^a,d   Lee, Eun Sook ^a   Cho, Youngnam ^a  

^a National Cancer Center   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

Cancer; Circulating cell free DNA; Conducting polymer; Liquid biopsy; Mutation detection; Nanowired structure

Indexed keywords

CIRCULATING CELL FREE DNA; DNA; UNCLASSIFIED DRUG; NANOWIRE; POLYMER; TUMOR MARKER;

ARTICLE; BLOOD ANALYSIS; BREAST CANCER; CLINICAL EFFECTIVENESS; DISEASE MARKER; DNA BINDING; DNA DETERMINATION; DNA EXTRACTION; DNA ISOLATION; ELECTROACTIVE CONDUCTING POLYMER NANOWIRE PLATFORM; ELECTROCHEMISTRY; ELECTROSTIMULATION; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE MUTATION; HUMAN; LUNG CANCER; NANODEVICE; OXIDATION; POLYMERASE CHAIN REACTION; THERANOSTIC NANOMEDICINE; BLOOD; BREAST NEOPLASMS; FEMALE; ISOLATION AND PURIFICATION; LUNG NEOPLASMS; PATHOLOGY;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; DNA; FEMALE; HUMANS; LUNG NEOPLASMS; NANOWIRES; POLYMERS;

EID: 84984801534     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.14695     Document Type: Article

References (35)

1. Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks R, Anderson DG. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer. 2012; 12: 39-50.
2. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer. 2005; 5: 161-171.
3. Chauhan VP, Jain RK. Strategies for advancing cancer nanomedicine. Nat. Mater. 2013; 12: 958-962.
4. Bidard FC, Weigelt B, Reis-Filho JS. Going with the flow: from circulating tumor cells to DNA. Sci. Transl. Med. 2013; 5: 207.
5. De Mattos-Arruda L, Cortes J, Santarpia L, Vivancos A, Tabernero J, Reis-Filho JS, Seoane J. Circulating tumour cells and cell-free DNA as tools for managing breast cancer. Nat. Rev. Clin. Oncol. 2013; 10: 377-389.
6. Diaz LA, Bardelli A, Clin J. Liquid biopsies: genotyping circulating tumor DNA. Oncol. 2014; 32: 579-586.
7. Elshimali YI, Khaddour H, Sarkissyan M, Wu Y, Vadgama JV. The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients. Int. J. Mol. Sci. 2013; 14: 18925-18958.
8. Heitzer E, Ulz P, Geigl JB. Circulating tumor DNA as a liquid biopsy for cancer.Clin. Chem. 2015; 61: 112-123.
9. Yoshioka Y, Kosaka N, Konishi Y, Ohta H, Okamoto H, Sonoda H, Nonaka R, Yamamoto H, Ishii H, Mori M, Furuta K, Nakajima T, Hayashi H, Sugisaki H, Higashimoto H, Kato T, Takeshita F, Ochiya T. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat. Commun. 2014; 5: 3591.
10. Benesova L, Belsanova B, Suchanek S, Kopeckova M, Minarikova P, Lipska L, Levy M, Visokai V, Zavoral M, Minariket M. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients. Anal. Biochem. 2013; 433: 227-234.
11. McLarty JL, Yhf CH. Circulating Cell-Free DNA: The Blood Biopsy in Cancer Management. Cell. Sci. Rep. 2015; 2: 00021.
12. Speicher M, Pantel K. Tumor signatures in the blood. Nat. Biotechnol. 2014; 32: 441-443.
13. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer. 2011; 11: 426-437.
14. Spellman PT, Gray JW. Detecting cancer by monitoring circulating tumor DNA. Nat. Med. 2014; 20: 474-475.
15. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong SM, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Marie SKN, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Bianchi AS, Schmidt K, Shih le-M, Shinjo SMO, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang TL, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz LA Jr. Detection of circulating tumor DNA in earlyand late-stage human malignancies. Sci. Transl. Med. 2014; 6: 224-24.
16. Board RE, Williams VS, Knight L, Shaw J, Greystoke A, Ranson M, Dive C, Blackhall FH, Hughes A. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer. Ann. N. Y. Acad. Sci. 2008; 1137:98-107.
17. Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW Jr, Alizadeh AA, Diehn M. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med. 2014; 20: 548-554.
18. Taniguchi K, Uchida J, Nishino K, Kumagai T, Okuyama T, Okami J, Higashiyama M, Kodama K, Imamura F, Kato K. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas. Clin. Cancer Res. 2011; 17: 7808-7815.
19. Jeon S, Moon J, Lee E, Kim Y, Cho NY. An electroactive biotin-doped polypyrrole substrate that immobilizes and releases EpCAM-positive cancer cells. Angew. Chem. Int. Ed. 2014; 53: 4597-4602.
20. Hong WY, Jeon S, Lee E, Cho YN. An integrated multifunctional platform based on biotin-doped conducting polymer nanowires for cell capture, release, and electrochemical sensing. Biomaterials 2014; 35: 9573-9580.
21. Jeon S, Hong WY, Lee E, Cho YN. High-purity isolation and recovery of circulating tumor cells using conducting polymer-deposited microfluidic device. Theranostics 2014; 4: 1123-1132.
22. Pernaut JM, Reynolds JR. Use of Conducting Electroactive Polymers for Drug Delivery and Sensing of Bioactive Molecules. A Redox Chemistry Approach. J Phys Chem. B 2000; 104: 4080-4090.
23. Wallace G, Spinks G. Conducting polymers -bridging the bionic interface. Soft Matter 2007; 3: 665-671.
24. Otero TF, Martinez JG. Biomimetic intracellular matrix (ICM) materials, properties and functions. Full integration of actuators and sensors. J Mater Chem. B 2013; 1: 26-38.
25. Dai Y, Blaisten-Barojas E. Energetics, structure, and charge distribution of reduced and oxidized n-pyrrole oligomers: a density functional approach. J. Chem. Phys. 2008; 129: 164903.
26. Tsai YT, Choi CH, Gao N, Yang EH. Tunable wetting mechanism of polypyrrole surfaces and low-voltage droplet manipulation via redox. Langmuir 2011; 27: 4249-4256.
27. Xiaohua J, Xiangqin L. Overoxidized polypyrrole film directed DNA immobilization for construction of electrochemical micro-biosensors and simultaneous determination of serotonin and dopamine. Anal. Chim. Acta 2005; 537: 145-154.
28. Beck F, Braun O, Oberst M. Organic Electrochemistry in the Solid State-Overoxidation of Polypyrrole. Phys. Chem. 1987; 91: 967-974.
29. Schlenoff JB, Xu H. Evolution of Physical and Electrochemical Properties of Polypyrrole during Extended Oxidation. J. Electrochem. Soc. 1992; 139: 2397-2401.
30. Lewis TW, Wallace GG, Kim CY, Kim DY. Studies of the overoxidation of polypyrrole. Synthetic Met. 1997; 84: 403-404.
31. Fermin DJ, Teruel H, Scharifker BR. Changes in the population of neutral species and charge carriers during electrochemical oxidation of polypyrrole. J. Electroanal. Chem. 1996; 401: 207-214.
32. Page K, Hava N, Ward B, Brown J, Guttery DS, Ruangpratheep C, Blighe K, Sharma A, Walker RA, Coombes RC, Shaw JA. Detection of HER2 amplification in circulating free DNA in patients with breast cancer. Br. J. Cancer. 2011; 104: 1342-1348
33. Newman AM, Bratman SV, To J, Wynne J, Eclov NCW, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW Jr, Alizadeh AA, Diehn M. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med. 2014; 20: 548-556
34. Thress KS, Paweletz CP, Felip E, Cho BC, Stetson D, Dougherty B, Lai Z, Markovets A, Vivancos A, Kuang Y, Ercan D, Matthews SE, Cantarini M, Barrett JC, Jänne PA, Oxnard GR. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M. Nat. Med. 2015; 21: 560-564
35. Lebofsky R, Decraene C, Bernard V, Kamal M, Blin A, Leroy Q, Rio Frio T, Pierron G, Callens C, Bieche I, Saliou A, Madic J, Rouleau E, Bidard FC, Lantz O, Stern MH, Le Tourneau C, Pierga JY. Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types. Mol. Oncol. 2015; 9: 783-790